Please Wait.....
Report
In Vitro Diagnostics: Technologies and Global Markets
Market Research Report I 2025-01-22 I 159 Pages I BCC Research
Description
Report Scope
This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current and future market potential of in vitro diagnostic technology and includes an analysis of this market's competitive environment. The report covers market drivers, restraints, opportunities, product approvals, regulatory scenario assessments and emerging technologies. It features market projections and estimates of the market shares of key players through 2029.
In this analysis, the in vitro diagnostics market is segmented based on technologies, applications, end users and region. Based on technologies, the market is segmented into the following categories: hematology, immunochemistry, molecular diagnostics, POC testing, clinical microbiology and tissue diagnostics. Based on applications, the in vitro diagnostics market is segmented into these categories: diabetes, nephrology, blood glucose evaluation and monitoring (BGEM), oncology, cardiology, infectious diseases and other applications. The market is segmented based on end users into diagnostic laboratories, hospitals and clinics, point-of-care centers, and other end users.
The global in vitro diagnostics market has been segmented by the following geographical regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report features detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia and New Zealand (ANZ), Argentina, Brazil, South Africa, Mexico and the GCC countries. Market analysis data is provided for 2023, which serves as the base year, and estimates are given for 2024 and forecast values through 2029.
Report Includes
- 41 data tables and 54 additional tables
- Analysis of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Estimates of the size of the market for in vitro diagnostics (IVD) technologies, revenues, and market shares by technology, product, application, end user and region
- Assessment of market dynamics such as drivers, restraints and opportunities
- Discussion of how the rise in the number of respiratory infections, hospital acquired infections (HAIs), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
- Discussion of IVD for neglected infectious diseases, chemistry-based portable analysis and microfluidic platform-based POC tests
- A discussion on ESG challenges and practices in the industry
- Assessment of the competitive landscape, including the market shares of key companies, their product portfolios and financial overviews
- Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments and product launches
- Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Abbott, Sysmex Corp., Danaher, BD, and Siemens Healthineers AG
Executive Summary
Summary:
The global market for in vitro diagnostics was valued at $87.8 billion in 2023. The immunochemistry segment was valued at $31.1 billion in 2023 and is estimated to grow at 5.5% CAGR during the forecast period. This segment's market share of 35.5% in 2023 and its medium growth rate are attributed to factors such as the growth of the use of diagnosis procedures in clinics and the rise in demand for technologies to analyze blood samples for infections and disorders. The increase in virus or bacterial infection rates among different age groups has also increased the demand for immunochemistry procedures.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market and Technology Background
Introduction
In vitro Diagnostics Technology
Overview
Classification of In Vitro Diagnostic Elements
Importance of In Vitro Diagnostics Technologies and Quality Control
Difference Between In Vitro and In Vivo Diagnostics
Regulations in the IVD Industry
Regulation of IVD Products in Different Countries
Chapter 3 Market Dynamics
Overview
Market Drivers
Rise in Population of Older Adults: Dependence on Diagnosis Procedures
Integration of Artificial Intelligence in Vitro Diagnostics
Rising Prevalence of Chronic Diseases
Improving the Quality of Point-of-Care Testing (POCT)
Market Restraints
Challenges Associated with Technologies Product Packaging
Increases in Shipping Costs or Service Issues
Laboratory Assistant's Inability to Handle Laboratory Equipment and Consumables
Market Opportunities
Rise in Home Care Testing Devices
Demand for Point-of-Care (POC) Testing Units
Growing Demand for AI and the Internet of Things
Chapter 4 Emerging Technologies and Developments
Emerging Technologies in the IVD Market
Artificial Intelligence
Modified Old IVD Techniques
Liquid Biopsy
Automated In Vitro Diagnostic Devices
Emerging Developments in In Vitro Diagnostics
FDA Approval
Rise in Demand for Personalized Medicine
Lab Automation and Digital Health Platform
Portability Option in IVD Devices
Home Care Kits for Cancer Diagnosis
FDA Approved In Vitro Diagnostic Devices: AI Enabled
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Application
Diabetes
Nephrology
Blood Glucose Evaluation and Monitoring (BGEM)
Oncology
Cardiology
Infectious Diseases
Other Applications
Market Analysis by End User
Diagnostic Laboratory
Hospitals and Clinics
Point-of-Care (POC) Centers
Other End Users
Geographical Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Chapter 6 Competitive Intelligence
Introduction
Global Analysis of Company Market Ranking
Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
Agreements, Collaborations and Partnerships
bioMerieux Agreements
Siemens Healthineers and Sysmex Enter into a Global Agreement
Roche Enters into Agreement with Path AI
Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
In Vitro Diagnostics Companies and Start-Ups in 2021-2023
Diagopreutic Private Limited
Diatherax
IPLEXMED
Magnify Bioscience Inc.
Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Company Role in ESG Development
ESG Risk Ratings
BCC Research Viewpoint
Chapter 8 Appendix
Research Methodology
References
Company Profiles
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
JSR CORP.
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 1 : Approved FDA In Vitro Diagnostics Devices, 2021-2024
Table 2 : Differences Between In Vitro and In Vivo Diagnostics
Table 3 : FDA Approval of Artificial Intelligence and Machine Learning-Enabled Medical Devices, 2024
Table 4 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 5 : Global Market for In Vitro Diagnostics in Immunochemistry, by Region, Through 2029
Table 6 : Global Market for In Vitro Diagnostics in POC Testing, by Region, Through 2029
Table 7 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 8 : Global Market for In Vitro Diagnostics in Hematology, by Region, Through 2029
Table 9 : Global Market for In Vitro Diagnostics in Molecular Diagnostics, by Region, Through 2029
Table 10 : Global Market for In Vitro Diagnostics in Tissue Diagnostics, by Region, Through 2029
Table 11 : Global Market for In Vitro Diagnostics in Clinical Microbiology, by Region, Through 2029
Table 12 : Global Market for In Vitro Diagnostics, by Application, Through 2029
Table 13 : Global Market for Diabetes in In Vitro Diagnostics, by Region, Through 2029
Table 14 : Global Market for Nephrology in In Vitro Diagnostics, by Region, Through 2029
Table 15 : Global Market for BGEM in In Vitro Diagnostics, by Region, Through 2029
Table 16 : Global Market for Oncology in In Vitro Diagnostics, by Region, Through 2029
Table 17 : Global Market for Cardiology in In Vitro Diagnostics, by Region, Through 2029
Table 18 : Global Market for Infectious Diseases in In Vitro Diagnostics, by Region, Through 2029
Table 19 : Global Market for Other Applications in In Vitro Diagnostics, by Region, Through 2029
Table 20 : Global Market for In Vitro Diagnostics, by End User, Through 2029
Table 21 : Global Market for In Vitro Diagnostics for Diagnostic Laboratory, by Region, Through 2029
Table 22 : Global Market for In Vitro Diagnostics for Hospitals and Clinics, by Region, Through 2029
Table 23 : Global Market for In Vitro Diagnostics for Point-of-Care Centers, by Region, Through 2029
Table 24 : Global Market for In Vitro Diagnostics for Other End Users, by Region, Through 2029
Table 25 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 26 : North American Market for In Vitro Diagnostics, by Country, Through 2029
Table 27 : European Market for In Vitro Diagnostics, by Country, Through 2029
Table 28 : Asia-Pacific Market for In Vitro Diagnostics, by Country, Through 2029
Table 29 : Latin American Market for In Vitro Diagnostics, by Sub-Region, Through 2029
Table 30 : Total Imports of Medical Equipment into Brazil, 2021 and 2022
Table 31 : Middle Eastern and African Market for In Vitro Diagnostics Technology, by Sub-Region, Through 2029
Table 32 : bioMerieux Agreements
Table 33 : ESG Practices: Environmental Performance
Table 34 : ESG Practices: Social Performance
Table 35 : ESG Practices: Governance Performance
Table 36 : Creating an Attractive Workplace: Social Performance
Table 37 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 38 : Abbott: Company Snapshot
Table 39 : Abbott: Financial Performance, FY 2022 and 2023
Table 40 : Abbott: Product Portfolio
Table 41 : Abbott: News/Key Developments, 2022-2024
Table 42 : BD: Company Snapshot
Table 43 : BD: Financial Performance, FY 2022 and 2023
Table 44 : BD: Product Portfolio
Table 45 : BD: News/Key Developments, 2022-2024
Table 46 : BIOMERIEUX: Company Snapshot
Table 47 : BIOMERIEUX: Financial Performance, FY 2022 and 2023
Table 48 : BIOMERIEUX: Product Portfolio
Table 49 : BIOMERIEUX: News/Key Developments, 2023 and 2024
Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 53 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 54 : Bio-Techne: Company Snapshot
Table 55 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 56 : Bio-Techne: Product Portfolio
Table 57 : Bio-Techne: News/Key Developments, 2022 and 2023
Table 58 : Bruker: Company Snapshot
Table 59 : Bruker: Financial Performance, FY 2022 and 2023
Table 60 : Bruker: Product Portfolio
Table 61 : Bruker: News/Key Developments, 2021-2024
Table 62 : Danaher Corp.: Company Snapshot
Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64 : Danaher Corp.: Product Portfolio
Table 65 : Danaher Corp.: News/Key Developments, 2021-2023
Table 66 : EKF Diagnostics Holdings plc.: Company Snapshot
Table 67 : EKF Diagnostics Holdings plc.: Financial Performance, FY 2022 and 2023
Table 68 : EKF Diagnostics Holdings plc.: Product Portfolio
Table 69 : EKF Diagnostics Holdings plc.: News/Key Developments, 2022-2024
Table 70 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 71 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 72 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 73 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 74 : Hologic Inc.: Company Snapshot
Table 75 : Hologic Inc.: Financial Performance, FY 2022 and 2023
Table 76 : Hologic Inc.: Product Portfolio
Table 77 : Hologic Inc.: News/Key Developments, 2022-2024
Table 78 : JSR Corp.: Company Snapshot
Table 79 : JSR Corp.: Financial Performance, FY 2022 and 2023
Table 80 : JSR Corp.: Product Portfolio
Table 81 : JSR Corp.: News/Key Developments, 2024
Table 82 : QuidelOrtho Corp.: Company Snapshot
Table 83 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 84 : QuidelOrtho Corp.: Product Portfolio
Table 85 : QuidelOrtho Corp.: News/Key Developments, 2021-2024
Table 86 : Siemens Healthineers AG: Company Snapshot
Table 87 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 88 : Siemens Healthineers AG: Product Portfolio
Table 89 : Siemens Healthineers AG: News/Key Developments, 2021-2024
Table 90 : Sysmex Corp.: Company Snapshot
Table 91 : Sysmex Corp.: Financial Performance, FY 2022 and 2023
Table 92 : Sysmex Corp.: Product Portfolio
Table 93 : Sysmex Corp.: News/Key Developments, 2022 and 2023
Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 97 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
List of Figures
Summary Figure : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 1 : Snapshot of Market Dynamics
Figure 2 : Older Adults Using Technology to Manage Chronic Health Issues in the U.S., by Age Group, 2024
Figure 3 : Percentage of People Aged 50+ Using Digital Services in the U.S., 2024
Figure 4 : Breakdown of Global Elderly Population (Aged 65+ Years), by Select Countries, 2022
Figure 5 : Emerging AI Applications in In Vitro Diagnostics
Figure 6 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 7 : Global Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 8 : Snapshot of IVD Tests in Oncology
Figure 9 : Global Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 10 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 11 : North American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 12 : North American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 13 : North American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 14 : North American Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 15 : European Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 16 : European Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 17 : European Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 18 : European Market Shares of In Vitro Diagnostics, by Sub-Region , 2023
Figure 19 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 20 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 21 : Asia-Pacific Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 22 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 23 : Latin American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 24 : Latin American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 25 : Latin American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 26 : Latin American Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 27 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 28 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 29 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 30 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 31 : Rankings of Leading Companies in Global In Vitro Diagnostics Market, 2023
Figure 32 : Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 33 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 34 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 35 : BD: Revenue Shares, by Business Unit, FY 2023
Figure 36 : BD: Revenue Shares, by Country/Region, FY 2023
Figure 37 : BIOMERIEUX: Revenue Shares, by Business Unit, FY 2023
Figure 38 : BIOMERIEUX: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023
Figure 42 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023
Figure 43 : Bruker: Revenue Shares, by Business Unit, FY 2023
Figure 44 : Bruker: Revenue Shares, by Country/Region, FY 2023
Figure 45 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 46 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 47 : EKF Diagnostics Holdings plc.: Revenue Shares, by Business Unit, FY 2023
Figure 48 : EKF Diagnostics Holdings plc.: Revenue Shares, by Country/Region, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 51 : Hologic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Hologic Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 53 : JSR Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 54 : JSR Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 55 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 57 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 58 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
Figure 59 : Sysmex Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 60 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 61 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 62 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security